CDC Ranks Drug-Resistant Germs; C. Diff Eases

The 2026 report rates four resistant pathogens as Urgent and lowers C. difficile to Serious after measured case declines.

Updated on Nov. 12, 2026 in Diseases — General

Isometric editorial illustration of four petri dishes of descending height on a slate ledge, each holding a different colony texture, rendered in muted oxblood, teal, and cream.
The CDC's 2026 antimicrobial resistance report ranks 19 drug-resistant germs by threat level, moving C. difficile down from Urgent to Serious. AI Illustration. Upload story photo >

Live Poll

Do you think drug-resistant infections are a growing threat to your health?

The CDC released its 2026 Antimicrobial Resistance Threats Report on October 26, 2026, ranking 19 bacterial and fungal pathogens by threat level to health in the United States. The report moved Clostridioides difficile down from Urgent to Serious based on measured declines in cases.

Why it matters

The threat rankings help set priorities for infection prevention, hospital practice, and public health spending as drug-resistant germs spread. Threat levels are based on clinical and economic impact, how many new infections are occurring and projected to change, how easily the germ spreads, and whether it can be prevented or effectively treated.

The ranking comes from CDC assessment of surveillance data on new infections, trends, and clinical and economic impact across the United States. The report expanded data collection for C. difficile to include both hospital and community cases, and for Enterobacterales and group A Streptococcus to capture more infection types.

The players

Centers for Disease Control and Prevention (CDC)

The U.S. federal public health agency that tracks infectious disease, runs national antimicrobial resistance surveillance, and publishes the threat assessments that guide prevention efforts.

The details

Pathogens are placed in one of four tiers based on how much harm they cause, whether new infections are rising or falling, how readily they spread between people, and whether there are effective prevention tools or treatments. Candida auris, carbapenem-resistant Acinetobacter, carbapenem-resistant Enterobacterales, and drug-resistant Neisseria gonorrhoeae were classified as Urgent threats. Drug-resistant Neisseria meningitidis was added at the Serious level, while drug-resistant dermatophytes, drug-resistant Haemophilus influenzae, and nontuberculous mycobacteria were added to the Watch List.

Timeline

  1. October 26, 2026: CDC published the 2026 Antimicrobial Resistance Threats Report.

  2. November 11, 2026: Contagion Live published an article on the report.

Health Landscape

The CDC's periodic threat reports serve as the main federal tool for tracking which drug-resistant germs need the most attention. This year's downgrade of C. difficile shows that some resistance threats can be brought under control with infection prevention, while newly flagged organisms signal emerging concerns.

Antibiotic-resistant infections are most likely to come up in hospitals, long-term care settings, and after recent antibiotic or medical procedures, so it is worth asking your clinician about infection prevention when you receive care. If you have a recurring infection or a symptom that is not responding to standard treatment, it is reasonable to ask your doctor whether a resistant organism could be a factor.

The takeaway

Some drug-resistant infections are improving with prevention, while others are newly flagged, which makes ongoing surveillance important. If you have questions about infection risk or antibiotic use, bring them to your physician.

Further reading

For broader context on how infections and their treatments are tracked, explore the Diseases — General section.

More information

Read the full CDC Antimicrobial Resistance Threats Reports on the agency's official site.

Live Poll

Do you think drug-resistant infections are a growing threat to your health?